European multicenter study on propionyl-L-carnitine in intermittent claudication
- 29 October 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 34 (5) , 1618-1624
- https://doi.org/10.1016/s0735-1097(99)00373-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Current and Future Drug Therapies for ClaudicationVascular Medicine, 1997
- Effect of Propionyl-L-Carnitine on Quality of Life in Intermittent ClaudicationThe American Journal of Cardiology, 1997
- Carnitine-Related Alterations in Patients With Intermittent ClaudicationCirculation, 1996
- Propionyl-l-carnitine in intermittent claudication: Double-blind, placebo-controlled, dose titration, multicenter studyJournal of the American College of Cardiology, 1995
- The impact of intermittent claudication on quality of life evaluated by the Sickness Impact Profile techniqueEuropean Journal of Clinical Investigation, 1993
- Muscle carnitine deficiency in patients with severe peripheral vascular disease.Circulation, 1991
- Carnitine and acylcarnitine metabolism during exercise in humans. Dependence on skeletal muscle metabolic state.Journal of Clinical Investigation, 1989
- Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965‐1985 [see comments]British Journal of Clinical Pharmacology, 1988
- Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study.Circulation, 1988
- Carnitine metabolism during exercise in patients with peripheral vascular diseaseJournal of Applied Physiology, 1987